20-F/A

FORM 20-F AMENDMENT NO. 1

Company: NYMOX PHARMACEUTICAL CORP
Filed: May 11, 2018
Period of Report: December 31, 2017
Accession Number: 0001640334-18-000936

View Document ↗ View on SEC.gov ↗